Page last updated: 2024-08-24

3-iodobenzylguanidine and Chagas Cardiomyopathy

3-iodobenzylguanidine has been researched along with Chagas Cardiomyopathy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Camargo, GC; de Almeida, SA; de Brito, ASX; de Holanda, MT; de Sousa, AS; Glavam, AP; Mendes, FSNS; Moll-Bernardes, RJ; Oliveira, RS; Pinheiro, MVT; Rosado-de-Castro, PH; Sangenis, LHC; Siqueira, FPR1
Barizon, GC; Gadioli, LP; Murta Junior, LO; Schmidt, A; Simões, MV1
Morillo, CA; Velasco, A1
Braga, DS; Dumont, SM; Freitas, SS; Marino, VSP; Moreira, MDCV; Mota, LDG1
Antloga, CM; Bromberg-Marin, G; Maciel, BC; Marin-Neto, JA; Pazin-Filho, A; Pintya, AO; Sarabanda, AV; Simões, MV1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Chagas Cardiomyopathy

ArticleYear
Chagas heart disease: A contemporary review.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2

    Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chagas Disease; Electrocardiography; Heart; Heart Diseases; Humans; Insect Vectors; Insecta; Prognosis; Radionuclide Imaging; Risk; Treatment Outcome; Trypanosoma cruzi

2020

Trials

1 trial(s) available for 3-iodobenzylguanidine and Chagas Cardiomyopathy

ArticleYear
Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy.
    The American journal of cardiology, 2000, Nov-01, Volume: 86, Issue:9

    Topics: 3-Iodobenzylguanidine; Adult; Analysis of Variance; Chagas Cardiomyopathy; Female; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Probability; Radionuclide Imaging; Reference Values; Regional Blood Flow; Sensitivity and Specificity; Statistics, Nonparametric; Sympathectomy; Sympathetic Nervous System; Thallium Radioisotopes; Ventricular Dysfunction, Left

2000

Other Studies

3 other study(ies) available for 3-iodobenzylguanidine and Chagas Cardiomyopathy

ArticleYear
Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:6

    Topics: 3-Iodobenzylguanidine; Autonomic Denervation; Chagas Cardiomyopathy; Chagas Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Fibrosis; Gadolinium; Humans; Myocardial Ischemia; Ventricular Premature Complexes

2023
Relationship between microvascular changes, autonomic denervation, and myocardial fibrosis in Chagas cardiomyopathy: Evaluation by MRI and SPECT imaging.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Denervation; Autonomic Nervous System; Chagas Cardiomyopathy; Female; Fibrosis; Heart; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2020
Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients.
    Arquivos brasileiros de cardiologia, 2018, Volume: 111, Issue:2

    Topics: 3-Iodobenzylguanidine; Adult; Chagas Cardiomyopathy; Cross-Sectional Studies; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Primary Dysautonomias; Radionuclide Imaging; Radiopharmaceuticals

2018